Received May 29, 2012 <Accepted October 15, 2012 The triorganotin compound trimethyltin (TMT) is a highly toxic molecule which has a great impact on human health. The aim of this study was to investigate the specific alteration of dopamine receptors and transporters in the hippocampus of TMT-treated rats. The TMT-treated group showed impaired spatial reference memory in a Morris water maze task compared to the control group, whereas memory consolidation tested 24 hours after the last training session was preserved. In the open field, TMT-treated rats showed a decrease in time spent in rearing episodes reflecting a lower interest to explore a novel environment. In the hippocampal area of the TMT-treated group, we observed a reduction in neuronal viability accompanied by a significant decrease in the expression of the dopamine receptors (Dl and D2), and dopamine transporters (DAT, VMATI and VMAT2). A less pronounced reduction was observed for D3 and D5 while D4 did not change. These data were confirmed by RT-PCR analysis. The present study on TMT-induced neurodegeneration highlights the link between hippocampal asset of dopamine receptors and transporters and the impaired performance of rats in a spatial reference memory task.
Dopamine
(DA) is a catecholamine neurotransmitter present in both vertebrates and invertebrates whose functions are mediated by five dopamine receptors expressed in several organs and tissues, such as central and peripheral nervous system, gastrointestinal tract, kidney, and cardiovascular system (1, 2) . The extracellular lifetime of dopamine is controlled by a specific transporter DAT (dopamine plasma membrane transporter) and by unselective monoamine vesicular transporters VMATl and VMAT2 (3) . Recently, the dopamine receptors and transporters were also characterized, at the microanatomical level, in rat thymus and spleen (4, 5) and in the native human heart (6) .
The triorganotin compound trimethyltin (TMT), occasionally produced as an intermediate in manufacturing processes of organotin compounds, has a great impact on human health. TMT is well known as a potent neurotoxicant affecting selectively the limbic system, especially the hippocampus (7, 8) . In experimental animals, TMT administration significantly decreased dopamine levels in striatum (9) and induced damage in the brain (10) , disturbing the activity within the neuronal network and affecting the synaptic processes (11) . To date, there is very little literature available on the interaction of this xenobiotic with the dopaminergic system.
It is well established that learning and memory are complex processes involving and recruiting different brain modulatory neurotransmitter systems. The mechanisms underlying memory formation in the hippocampal network remain a major unanswered aspect ofneuroscience. Extensive evidence supports the role of glutamate receptors in long-lasting synaptic plasticity (12) and spatial learning and memory (13) . Besides, there is evidence regarding the modulatory role of dopamine receptors in the LTP-like potentiation in the hippocampus; in particular, the activation of Dl/D5 receptors during memory encoding can facilitate the induction of CAl LTP for the formation of a persistent memory trace in the hippocampus (14, 15) .
In the present work, we investigated the specific alteration of dopamine receptors and transporters in rat hippocampus after TMT administration. Since hippocampal formation is involved in spatial learning, the performance of animals was examined in a Morris water Maze task in order to correlate dopaminergic function with learning and memory abilities.
MATERIALS AND METHODS

Animals
Male Wistar rats (Harlan, Italy), weighing 250 g, and about 7 weeks old were used. Animals were housed in plastic (Makrolon) cages in a temperature and humiditycontrolled room (2l±5°C and 60% humidity) and were fed ad libitum with standard laboratory diet and water. The light/dark cycle was from 7 a.m. to 7 p.m. (lights on at 7:00 p.m.). The animals used in this study complied with the Directive 20 I0/63IEU of the European Parliament and of the Council of22 September 2010 for Care and Use of Laboratory Animals. All efforts were made to minimize animal suffering, to reduce the number of animals used, and to utilize alternatives to in vivo techniques, if available.
Drug administration and tissue treatment
Trimethyltin chloride (Heraeus, Karlsruhe, Germany) was solubilized in 0.9% saline at a concentration 8 mg! ml. Thirty-two rats were divided into two groups (n=16 each) and treated as follow: the control group received an intraperitoneal (i.p.) injection of vehicle (0.9% saline, control group), whereas the treated group (TMT-treated group) received an i.p. injection oftrimethyltin (8 mg/kg).
The volume of the compound administered was adjusted based on body weight. Seven and fourteen days after the acute treatment, 4 rats per group were sacrificed, by exposure to CO 2 for Neu-N immunohistochemistry analysis of hippocampus, whereas the remaining 8 rats per group were sacrificed 21 days after the acute treatment, at the end of the behavioural testings. From the latter, hippocampus from 4 animals per group were used for PCR analysis, whereas the other 4 brains per group were used for immunohistochemistry. For PCR analysis, the hippocampus was dissected out and a stereotaxic atlas was used as reference (16) .
Water maze test
Seven days after TMT treatment, rats (n=8 per group) were trained in a standard Morris water maze task in order to assess their spatial learning and memory consolidation. The maze consisted ofa large, circular tank (diameter 150 em; wall height 60 em) filled with water (23-25°C) and placed in the centre of a large room with extramaze cues. An escape platform was located 1 em beneath the water surface in a fixed position and a nontoxic black paint was added to obscure the platform and to aid tracking of the animals' swim paths. In order to escape from the water the rats had to find the hidden escape platform located in the same position across all days of training. Animal performance was tracked by video using EthoVision 7.0 software (Noldus Information Technology, The Netherlands). Briefly, rats received four trials per day for seven consecutive days using a 30 s intertrial interval. On each training trial, rats were placed in the water and allowed to swim until finding the platform or for 90 s at which time they were placed on the platform by the experimenter. Once on the platform, rats were allowed 30 s to acquire memory of its position using the surrounding cues. The start position for each trial was varied pseudorandomly among four equally spaced positions around the perimeter of the pool. Latency to escape platform was the dependent measure, with shorter latency times indicating better performance. Mean proximity to escape platform was recorded as the primary measure of the animal's cognitive ability based on demonstration of its superior sensitivity compared to alternative measures (17) . Lower scores on the proximity to escape platform indicate a more accu~ate search because of short distance of rat to the platform during the trial.
A memory test or probe trial, on day 8, was carried out 24 h after the last training session in which the platform had been removed from the pool to measure the time spent in the target quadrant where the platform was located during the training. This assessment provided an estimate ofthe strength and accuracy ofthe memory ofthe previous platform location (spatial memory consolidation).
Measurement oflocomotor activity
In order to avoid interference with the memory tests, the locomotor activity of rats (n=8 per group) was tested at the end of the memory consolidation test 20 days after the acute treatment. Automated locomotor activity boxes (Med Associates, VT 05478) were used to quantify the behavioural activity as previously reported (18) . Each animal was placed in the activity box and spontaneous locomotor activity parameters were monitored. Activity was recorded for 5 min, starting 1 min after placing the animal in the test cage. Each rat was automatically recorded by interruptions of two orthogonal light beams (3.5 and 13.0 em above the activity box floor), which were connected to automatic softwares (Activity Monitor, Med Associates). The behavioural tests were performed 20 days after the acute treatment, one day before blood collection. The behavioural parameters observed were ambulatory (number of ambulatory episodes), rearing (number of rears), and stereotype counts (number of grooming movements). Ambulatory counts were recorded when the low row of photocells was interrupted, while rearing counts were recorded by taking the higher row of photocells. The open field is divided into two squares, and ambulatory, rearing and stereotype counts into the central area (25 em x 25 em) which can be considered an unprotected area for rats, were recorded. These parameters are expressed as percentage of total ambulatory, rearing and stereotype counts, respectively. Low percentage of activities in the central area could represent behaviour correlated with anxiety (19) . Between each test session, the apparatus was cleaned with alcohol (10%) and dried with a cloth.
Immunohistochemistry
Sagittal brain sections ofthe hippocampus were cut (15 urn) serially (1.40 mm to 2.40 mm from the edge) using a -20°C cryostat and post-fixed in a solution 1:1 methanolacetone. The first section was stained with cresil violet to evaluate microanatomical details and consequential sections were used for the Neu-N immunohistochemical detection, dopamine receptors (Dl, D2, D3, D4, D5), dopamine transporters (DAT, VMATl and VMAT2) and for the assessment of the specificity of immune reaction (control sections). After endogenous peroxidase activity was blocked by 1% HPz (10 min), the slides were preincubated for 1h at room temperature in a 3% albumin from bovine serum (BSA) dissolved in O.IM phosphate buffered saline (PBS) and 0.3% Triton X-100, finally incubated with primary antibodies (Table I) overnight at 4°C. Slides were rinsed several times in PBS and incubated with a biotynilated secondary antibodies (Table I ) dissolved in PBSI 0.3% Triton X-I00 for I h at room temperature. To assess the immune reaction biotin-streptavidin immunostaining kit with 0.05% diaminobenzidine (DAB) in 0.1% HzO z was used. The product of immune reaction was visualised by computer-driven densitometry with an IAAS 2000 image analyser (Delta Sistemi, Rome, Italy).
RNA extraction and RT-PCR analysis
Total RNA was extracted from hippocampus using PureLink ™ RNA Mini Kit (Invitrogen) as indicated in the User Manual. The RNA (20 ng) was transcribed in vitro to cDNA by using Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Fermentas, Life Science, M-Medical srl, Cornaredo, Italy). I III of each cDNA sample was amplified using 2xPCR Master Mix (Fermentas) and 10 pmol of each specific primer listed in Table IIA For real time PCR analysis, total RNA was isolated from the hippocampus using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). The obtained RNA was quantitated by the UV absorption ratio 260:280 nm using a UVI visible spectrophotometer (SmartSpec 3000, Bio-Rad Laboratories, Hercules, CA, USA). l ug oftotal RNA was reverse transcribed using cDNA Synthesis kit (Bioline, London, UK) according to the manufacturer's instructions. After reverse transcription, cDNA was diluted 1:4 and 5 III were amplified by real-time PCR in 25 III using SYBR Green master mix (SensiMix SYBR kit, Bioline, London, UK) in a ABI 7500 Real-Time PCR system (Bio-Rad Laboratories, Hercules, CA, USA). Amplification started with an initial activation step at 95°C for 10 min followed by 40 cycles consisting of denaturation (15 s) at 95°C, annealing (15 s) at 55°C and extension (15 s) at n°e.
Primer sequences were designed using IDT Scitools (IDT, Integrated Technologies, Germany) and were reported in Table lIB . Ribosomal 5S RNA was selected as control housekeeping gene. All reactions were performed in duplicate.
Statistical analysis
Statistical 9.0 software was used by applying a oneway ANOVA except for body weight and water maze analysis where a two-way ANOVA with one factor within (time) and one factor between (treatment) was employed. Ifa general effect was determined by ANOVA, Newman-Keuls post hoc analysis was performed with p < 0.05 used as the level of significance.
RESULTS
TMT effect on body weight
Rats treated once with vehicle or TMT showed no signs of gross physical abnormalities (hair coat, colour of mucosa and skin) throughout the experimental period. Data on body weight in all treated and control rats are reported in Fig. 1 . The TMT-treated group did not show differences in body weight respect to the control group during 21 days of experiment indicating a not significant drug effect on body weight (F[I,14] = 0.065, p>0.05). A significant time effect indicated that the animals were growing during the interval of time considered (F[3,42]=111,44, p<O.OOI).
TMT effect on spatial learning and memory
We investigated the effect of TMT on learning and memory in a rat model treated acutely with TMT. In Fig. 2 , the results showed that learning was significantly impaired in the TMT-treated group in respect to the control group. Two-way ANOVA for repeated measures showed a significant effect of treatment on distance travelled (F[I,62] =17.53; p<O.OOI), time spent to find the platform (F[I,62] =18.76; p<O.OOI) and on proximity to target (F[I,62] =24.75; p<O.OOI). Besides, two-way ANOVA for repeated measures showed a significant effect of treatment x day interaction on distance travelled [F(6,372) =3.36; p<O.OI] and on proximity to target (F [6, 372] =2.33; p<0.05). Newman-Keul post hoc analysis demonstrated that distance travelled of the TMT-treated group on day 3 (p<0.001), day 4 (p<0.005), day 5 (p<0.005) and day 6 (p<0.005) was significantly higher than that ofcontrol rats. Newman-Keul's test on proximity to target demonstrated that the performance of the TMT-treated group on day 2 (p <0.05), day 3 (p<0.0 1), day 4 (p<0.05) and day 5 (p<O.OOI) was significantly impaired with respect to the control group. However, despite this reduced learning, the memory consolidation of the TMTtreated group, at the probe test, was not impaired compared to the control group (p>0.05) as shown in Fig. 3 . These data indicated that TMT treatment impaired learning while memory consolidation, tested 24 h after training, was preserved.
TMT effect on locomotor activities
Locomotor activities of all rats were tested 20 days after TMT treatment in an open field task. One way ANOVA did not reveal differences between groups with regard to locomotor activities (ambulatory, stereotypic and vertical counts) as shown in Fig. 4 A and anxiety-like behaviour (% ambulatory, % stereotypic and % vertical counts) as reported in Fig. 4 B. Differences between treated and control groups were observed on time spent in rearing episodes, where TMT-treated rats showed a significant decrease in time spent in rearing episodes ( Fig. 4C, p<O.05 ). Rearing is defined as exploratory behaviour and it refers to those behaviours in which an animal appears to take a certain initiative in finding out more about its environment. Less time 
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Immunohistochemistry
Neu-N immunostaining of the hippocampus showed a time-dependent loss of neurons after TMT treatment (Fig. 5 ). Consistently with previously published data (7, 8) , TMT caused neuronal loss accompanied by reactive gliosis mainly in the CA3 and hilus region ( Fig. 6 ). At 21 days ofTMT treatment the neuronal loss reaches maximum severity and Neu-N immunoreactivity was reduced by about 46% in TMT-treated rats in respect to control in the CAl area of the hippocampus (p<0.05) ( Figs. 6 and 7) . Immunohistochemical image analysis indicated a general reduction of dopaminergic markers in the hippocampus of TMT-treated rats compared with that observed in control rats; the immune reaction was significantly (p<0.05) decreased, at 21 days after TMT treatment, in the hippocampal area (Fig. 7) . In particular, D2 receptor and VMAT2 were reduced by 72%; DAT, Dl and VMATl were reduced by 64%, 57% and 60%, respectively; a less pronounced reduction was observed for D3 and D5 (27% and 39%, respectively); D4 did not change. After TMT administration, dopamine immunoreactivity was unchanged (data not shown). Fig. 8 shows semiquantitative PCR analysis of DI, D2, D3, D5, VMATl, VMAT2 and DAT in the hippocampus of rats previously treated with TMT and sacrificed after 21 days. In particular, a general reduction of gene expression was observed for all dopaminergic parameters analysed as reported.
In Fig. 9 , Real-time PCR analysis ofDI, D2, D3, D4, D5, VMATl, VMAT2 and DAT mRNA levels is reported. In the hippocampus the mRNA levels of all dopaminergic markers except D4 showed a marked decrease following TMT administration. In particular, D2, VMATl and VMAT2 mRNA level in TMT treated rats was reduced by 91%, 88 and 96%, respectively (p<O.O 1).
DISCUSSION
Mesolimbic dopamine pathway plays an important role in learning and memory and the hippocampus is one ofthe main structures implicated in these processes, although learning also depends on multiple cortical and subcortical structures, including striatum and amygdala. Despite some authors have reported that cognitive changes are accompanied by a degree of pathological damage to the hippocampal pyramidal cells in TMT intoxicated animals (20) and that dopaminergic neurotransmitter systems have been implicated in learning and memory consolidation (21) , the role of dopamine (DA) and its receptors and transporters is less clear. The present study on TMT-induced neurodegeneration highlights the link between hippocampal asset of dopamine receptors and transporters and the impaired performance of rats in a spatial reference memory task. We have observed that TMT neurodegeneration: i) determined a general reduction ofall dopaminergic marker expression in the hippocampus, without dopamine reduction; ii) reduced D1 and D2 levels maintaining the D1 and D2 ratio, iii) impaired spatial learning whereas memory consolidation was preserved when animals were tested 24 h after training; iiii) decreased significantly the time spent in rearing counts.
The Neu-N analysis in the hippocampal area showed that neuronal viability in the TMTtreated group was reduced by 46% vs the control group. Interestingly, the D1 receptor protein immunoreactivity in rats treated with TMT was significantly decreased by 57% versus that observed in control' rats. Besides, a decreased D2 gene expression possibly affecting the plasticity of inhibitory circuits was also observed. Dopamine D2 receptor is critical to regulate the dopaminergic pathway in the brain, therefore it is not surprising that most antipsychotic medications act on D 2-like family receptors. D2 receptors are also located on dopamine nerve terminals where their activation inhibits dopamine synthesis and release. They are also observed on dopamine cell bodies where they function to inhibit cell firing. Studies, where voltammetric methods have been used to monitor the rate of dopamine clearance in striatum, have shown that D2 agonists increase the V of max dopamine transporter (22, 23) , presumably through their action at presynaptic D2 level. Conversely, D2 antagonists decrease dopamine clearance (23), This effect is absent in mice lacking the gene encoding D2 receptor (24) suggesting a specific role of D2 in regulating DAT function. Some authors reported a direct physical interaction between DAT and D2 receptor (25) . The D1 receptor subtype impoverishment shown by our immunohistochemical analyses reflected the impaired performance of TMT-treated rats observed during the learning of a spatial reference memory task. This result is in agreement with previous work on dopamine D 1 receptor knockout mice showing spatial reference learning deficit in a Morris water maze (26) . In the memory consolidation test, TMT-treated rats did not display impairment most probably because of a counterbalance between D1 and D2 receptors despite their decrease of mRNA expression. In fact, studies of Huang and Kandel (27) revealed that D I dopamine agonists, positively coupled to adenylyl cyclase, induced a long-lasting potentiation of the field excitatory post-synaptic potential in the CAl region of the hippocampus , whereas this potentiation was not induced by a D2 agonist negatively coupled (27) .
Taken together, our data suggest that the cognitive impairment in the spatial learning task induced by TMT treatment was linked to hippocampal damage . On the contrary, treatment with TMT did not damage memory consolidation despite alterations being observed at the level of the dopaminergic system.
TMT presence could induce a redistribution of dopamine-containing vesicles away from synaptosomal membranes; in fact, TMT demonstrated to decrease VMAT2 and DAT. Especially the VMAT2 receptor protein immunoreactivity was significantly decreased by72%; this result was essentially confirmed by Real-time PCR analysis (96% reduction vs control group). We suggested here that these phenomena are mediated by D2 receptors, a hypothesis that could be demonstrated by pretreatment with the D2 receptor antagonist. VMAT2 is important for the sequestration of cytosolic dopamine protecting this catecholamine from oxidation and likely preventing excessive production of dopamine-related free radicals (28) . Reduced function and/or quantity of VMAT2 would presumably compromise normal functioning of the nerve terminal. Consistent with this hypothesis, VMAT2 function and VMAT2 protein levels were rapidly reduced following TMT treatment. Besides, TMT-induced decrease in VMAT2 persisted 21 days following TMT administration . VMAT2 protects dopamine from autoxidation and likely prevents excessive production of dopamine-related free radicals. This effect involves reactive oxygen species (ROS) formation as well as oxidative stress. Although the mere presence of this transporter does not appear to protect from damage, the monoaminergic cells might be more susceptible because of low VMAT2 level expression . The carefully controlled compartimentalization of dopamine and other potentially toxic substances is necessary to prevent undue internal cellular damage. Phylogenetically, VMAT2 is a member ofthe toxin-extruding antiporter (TEXAN) gene family (29) , and it has evolved to serve a dual purpose: preventing the interaction of toxins with molecular machinery and limiting exposure of neighboring cells to the toxin by sequestering the toxic substances into vesicles (30, 31) .
The immunohistochemical analysis suggests that, compared to control, endogenous dopamine levels are maintained after TMT treatment. Brain dopamine is important for establishing the conditioned tendency to re-approach environmental stimuli that have been associated with most primary rewards, and for maintaining habit strength once a task has been learned. Whatever the mechanism, dopaminergic system seems to stamp in response-reward and stimulus-reward associations that are essential for the control of motivated behaviour by past experience.
Overall, .these results suggest a differential involvement of the D l-type and D2-type receptors in the regulation of behaviours reflecting learning and memory, and that are likely mediated by different underlying states. Besides, we observed that the level of VMAT2 expression was essential to proper monoaminergic handling since it influenced the monoamine susceptibility to oxidation. Due to the resolution limits of microanatomical techniques used, further work is in progress to identify the different cellular populations (neuronal and/or glial cells) positive to dopamine and dopaminergic markers.
